By Benjamin Chiou
Date: Tuesday 04 Aug 2026
(Sharecast News) - Convatec reiterated its full-year guidance on Tuesday after delivering first-half results in line with expectations, with the medical products group forecasting stronger revenue and margins in the second half.
| Holding(s) in Company | 19-Dec-2025 | 12:00 | RNS |
| Convatec raises outlook with new specialist medi... | 25-Feb-2026 | Times |
No recent information was found.
No recent information was found.
| Currency | UK Pounds |
| Share Price | 226.40p |
| Change Today | 0.40p |
| % Change | 0.18 % |
| 52 Week High | 256.40p |
| 52 Week Low | 194.00p |
| Volume | 868,739 |
| Shares Issued | 1,942.37m |
| Market Cap | £4,397.53m |
| Beta | 0.00 |
| RiskGrade | 96 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 7 |
| Buy | 8 |
| Neutral | 2 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 18 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 20-Aug-26 | 16-Apr-26 |
| Paid | 30-Sep-26 | 28-May-26 |
| Amount | 2.17¢ | 5.37¢ |
| Time | Volume / Share Price |
| 14:12 | 1,053 @ 226.34p |
| 14:11 | 1,327 @ 226.20p |
| 14:11 | 1,300 @ 226.40p |
| 14:11 | 1 @ 226.40p |
| 14:11 | 1,700 @ 226.40p |
| Chair | John McAdam |
| CEO | Jonny Mason |
| CFO | Fiona Ryder |
You are here: research